Close
ACHEMA MIDDLE EAST 2026
5th LNP Formulation & Process Development Summit

Insights

      Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014

      Insights
      Orexigen® Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced corporate and financial results for the second quarter...

      NPS Pharma Reports Second-Quarter 2014 Financial Results

      Insights
      NPS Pharmaceuticals, Inc., a global biopharmaceutical company pioneering and delivering innovative therapies that transform the lives of patients with rare diseases, today reported its...

      Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2014 Financial Results

      Insights
      Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced financial results for the second quarter ending June 30, 2014. The...

      PTC Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update

      Insights
      PTC Therapeutics, Inc. today announced a corporate update and reported financial results for the second quarter ended June 30, 2014.   "This has been...

      Hill-Rom Reports Improved Fiscal Third Quarter Results; Updates Full-Year Guidance

      Insights
      -- Third quarter revenue of $398 million declined 6 percent versus prior year -- Adjusted diluted earnings per share for the third quarter of...

      Neurocrine Biosciences Reports Second Quarter 2014 Results

      Insights
      Neurocrine Biosciences, Inc. (NASDAQ: NBIX) today announced its financial results for the quarter ended June 30, 2014. For the second quarter of 2014, the...

      Thoratec Announces Start Of The HeartMate PHP™ CE Mark Trial

      Insights
      Thoratec Corporation (NASDAQ: THOR), a world leader in mechanical circulatory support therapies to save, support and restore failing hearts, announced today that its CE...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and
      comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector. . . Read More

      Resources

      Advertise

      Subscribe

      Copyright © Value Media Group 2026. All rights reserved.